Leerink Partners Initiates Tekmira Pharmaceuticals At Outperform
August 18, 2014 at 08:00 AM EDT
Analysts at Leerink Partners initiated coverage on Tekmira Pharmaceuticals (NASDAQ: TKMR) with a Outperform rating. The target price ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.